334
Views
20
CrossRef citations to date
0
Altmetric
Review

Non-NMDAR neuronal Ca2+–permeable channels in delayed neuronal death and as potential therapeutic targets for ischemic brain damage

, , , &
 

Abstract

Introduction: Transient cerebral ischemia represents the most common cause of complex chronic disability in adults due to delayed neuronal death as a result of aberrant post-ischemic increases in the [Ca2+]c and [Zn2+]c. A number of Ca2+-permeable channels are engaged in transient ischemia-induced neuronal death.

Areas covered: In this review, the authors discuss the GluA2-lacking AMPARs, acid-sensing ion channel 1a, melastatin-related transient receptor potential 2 (TRPM2), TRPM7 and store-operated Ca2+ channels expressed in ischemia-vulnerable neurons, and focus on the studies using in vitro and in vivo models of transient ischemia that supports a significant role for these channels in inducing increases in the [Ca2+]c and/or [Zn2+]c and delayed neuronal death, and their potential as therapeutic targets.

Expert opinion: Non-NMDAR Ca2+-permeable channels are important mechanisms mediating delayed neuronal death and cognitive dysfunctions after transient ischemia. Identification of such Ca2+-permeable channels significantly improves our understanding of the molecular events leading to ischemic brain damage and provides promising novel targets for post-ischemic therapeutics treating ischemic brain damage.

Acknowledgment

L Meng and X Li contributed equally to this work.

Declaration of interest

The work was supported in part by Xinxiang Medical University start-up founding (C Li and L-H Jiang), Natural Science Foundation of China (grant No.31471118 to L-H J). X Li is a recipient of University of Leeds-Chinese Scholar Council Scholarship. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Notes

This box summarizes key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.